Competitive Intelligence Services
Know What's Coming Before Your Competitors Do
Real-time healthcare competitive intelligence across clinical trials, regulatory milestones, conference activity, launches, and market signals, delivered through AI-powered dashboards and analyst-driven strategic reporting.
500+
Monitored Assets Globally
100+
Conferences Covered Annually
27+
Therapy Areas Tracked
300+
CI Engagements Delivered
Pharmaceutical Competitive Intelligence (CI) has traditionally relied on periodic analysis of competitor pipelines, clinical trials, regulatory updates, and market activities using fragmented data sources and manual research. While effective for basic monitoring, these conventional approaches often lack real-time visibility, comprehensive insights, and the speed needed to respond to rapidly changing market dynamics.
DelveInsight overcomes these limitations by combining AI-powered monitoring with expert analyst validation. By continuously tracking clinical, regulatory, scientific, and commercial developments, DelveInsight delivers actionable competitive intelligence that helps pharmaceutical and biotechnology companies identify emerging threats, uncover opportunities, and make faster, data-driven strategic decisions across the product lifecycle.
The CI Landscape
Why Pharma Teams Are Moving Beyond Spreadsheets
Most competitive intelligence companies fall into two categories: consulting firms that deliver project-based insights or data platforms that provide dashboards with little analysis. DelveInsight bridges this gap by combining continuously updated data with expert-driven intelligence.
Unlike traditional competitive intelligence software that prioritizes either data breadth or analytical depth, DelveInsight delivers both through an AI-powered platform. Clients gain access to 500+ monitored assets, natural language search, automated battlecards, and real-time competitive signals instead of static quarterly reports.
Whether you're benchmarking against other competitive intelligence companies, evaluating competitive intelligence analysis tools for an internal build-vs-buy decision, or simply tired of stitching together insights from five different competitive intel tools, the question isn't whether you need competitive intelligence in pharma; it's whether your current setup can keep pace with how fast competitor pipelines are actually moving.
Intelligence Coverage
What We Monitor
Our online competitive intelligence engine captures signals across every dimension of the competitive landscape, from early discovery activity to post-launch market dynamics, so your team never has to chase data across a dozen disconnected competitive intelligence analysis tools.
Clinical Trials
- ▸Enrollment status
- ▸FPI/LPI dates
- ▸Protocol amendments
- ▸Interim results
- ▸Trial design changes
Regulatory
- ▸IND/CTA filings
- ▸NDA/BLA submissions
- ▸MAA filings (EMA)
- ▸FDA/EMA decisions
- ▸Label updates
Commercial
- ▸Pricing signals
- ▸Market access
- ▸Payer negotiations
- ▸Launch timelines
- ▸Sales force activity
Conferences
- ▸ASCO/ESMO/AACR
- ▸ADA/ACC/ASH
- ▸Late-breaking abstracts
- ▸Poster sessions
- ▸Oral presentations
Publications
- ▸Peer-reviewed journals
- ▸Preprints (bioRxiv)
- ▸Congress posters
- ▸KOL commentaries
- ▸Review articles
Partnerships
- ▸Licensing deals
- ▸M&A activity
- ▸Co-development pacts
- ▸CDMO agreements
- ▸Platform alliances
Digital Signals
- ▸Hiring patterns
- ▸Website changes
- ▸Patent filings
- ▸Investor presentations
- ▸Job postings (MSL/KAM)
KOL Activity
- ▸Publication tracking
- ▸Speaking events
- ▸Advisory board roles
- ▸Opinion shift signals
- ▸Social engagement
Manufacturing
- ▸CDMO capacity
- ▸Supply chain alerts
- ▸CMO partnerships
- ▸Facility expansions
- ▸Tech transfer signals
Competitor Pipeline
- ▸Discovery → Phase I
- ▸Phase II / III
- ▸Pre-registration
- ▸Approval & Launch
- ▸Post-market activity
Methodology
The CI Intelligence Process
A rigorous six-stage methodology that converts raw, fragmented signals into executive-ready strategic recommendations, and feeds what's learned back into the system so the next cycle starts smarter.
Scoping & Intelligence Requirements
Before any monitoring begins, we define exactly what "relevant" means for your business, the assets, competitors, indications, and decisions this CI program needs to inform.
- Key Intelligence Topics (KITs) and Key Intelligence Questions (KIQs) are defined jointly with stakeholders.
- Competitor set, indication scope, and geography locked with your BD, commercial, or R&D lead.
- Decision-mapping: which signals trigger which actions, and who needs to see them first.
- Baseline landscape audit so day-one reporting has context, not just a blank feed.
Signal Collection
Always-on, multi-source monitoring across 150+ secondary and primary intelligence channels, built to catch the quiet signals, not just the press releases.
- Structured data feeds: ClinicalTrials.gov, EU CT, ICTRP, FDA/EMA dockets, patent filings, SEC/earnings transcripts.
- Unstructured capture: congress abstracts, KOL commentary, preprints, hiring activity, investor decks.
- Primary research layer: structured KOL interviews and advisory input where public data goes dark.
- Automated crawlers run continuously; nothing waits for a weekly batch job.
Validation & Triage
Volume isn't intelligence. This is where the noise gets filtered out before it ever reaches an analyst's real attention, let alone yours.
- Cross-source corroboration, a single unverified mention doesn't get flagged as a signal.
- Duplicate and stale-signal suppression across overlapping data feeds.
- Priority scoring (High/Medium/Low) based on materiality to your specific KITs.
- Analyst sign-off required before any signal moves to the analysis stage.
Analysis & Pattern Recognition
AI-assisted pattern detection surfaces connections across hundreds of data points; human analysts interpret what those connections actually mean for your competitive position.
- Trend and anomaly detection across pipeline movement, trial design, and regulatory pacing.
- Competitive benchmarking against your asset's TPP, timeline, and target indication.
- Frameworks applied as relevant: SWOT, war-gaming, scenario trees, win/loss patterning.
- Epidemiology and forecast models cross-checked against emerging competitive data.
Insight Generation & Recommendations
Analysis becomes intelligence only when it's translated into something a specific person can act on, so every output is built around a decision, not a data dump.
- Contextualized to your asset, indication, and the strategic question that prompted the engagement.
- "So what" framing on every finding, implication, and recommended action, not just observation.
- Function-specific packaging: CXO briefs, BD dossiers, commercial battlecards, R&D trial comparisons.
- Confidence levels and source transparency are attached to every recommendation.
Dissemination & Feedback Loop
Most CI processes stop at delivery. Ours doesn't; what stakeholders actually used (or ignored) reshapes what gets prioritized in the next cycle.
- Delivery via dashboard, newsletter, or direct briefing, matched to how each stakeholder actually consumes information.
- Stakeholder feedback captured on the accuracy, relevance, and timeliness of each deliverable.
- KITs/KIQs are revisited quarterly as your strategic priorities and competitive set evolve.
- Signal-to-outcome tracking: did the early warning hold up against what actually happened?
Technology
Real-Time CI Intelligence Platform
An AI-powered competitive intelligence platform purpose-built for pharma and biotech CI teams, combining live signal detection, competitor watchlists, and natural language querying with the kind of competitive analytics that turns raw data into a decision in minutes, not weeks.
AI-Powered Signal Detection
Machine-learning models trained on pharma CI data surface high-priority signals before they break in mainstream news.
Competitor Watchlists
Track specific assets, companies, or programs with customized alert thresholds and priority scoring.
Conference Intelligence
Pre-event program analysis, live abstract monitoring, and post-event competitor positioning summaries.
Natural Language Querying
Ask questions in plain English, "What did Roche present at ASCO on FL?", and receive structured, sourced answers.
Custom Battlecards
Auto-generated, analyst-validated battlecards for each competitor asset, updated on every significant signal event.
Deliverables
What Clients Receive
Every engagement is structured around concrete deliverables - not just access to data.
Weekly
Executive Intelligence Newsletter
Curated summary of the week's most significant competitive signals, organized by asset and indication, formatted for C-suite consumption.
Monthly
Strategic Competitive Reports
Deep-dive analysis of competitive dynamics, pipeline shifts, and market access developments with forward-looking implications.
Quarterly
Competitor Dossiers
Comprehensive profiles on key competitors covering pipeline, regulatory status, commercial strategy, and KOL sentiment.
Pre-Launch
Launch Readiness Assessments
Competitive positioning, payer landscape, and market access analysis timed to your asset's launch window.
Ongoing
Battlecards
Sales-ready, analyst-validated competitor comparison cards updated on every material signal event. Delivered in PowerPoint and dashboard format.
Event-Driven
Early Warning Reports
Immediate alert packages triggered by competitor FDA approvals, trial failures, M&A announcements, or late-breaking data.
Post-Congress
Conference Intelligence Reports
Abstract analysis, competitive positioning shifts, and KOL sentiment capture from ASCO, ESMO, AACR, ADA, and 50+ other congresses.
Continuous
Clinical Trial Monitoring Reports
Structured trial intelligence including design, enrollment, endpoints, and protocol amendments for each tracked competitor asset.
Strategic
Scenario Planning Reports
What-if analysis across competitive scenarios - approval timelines, pricing shifts, combination therapy moves - with probabilistic framing.
Expertise
Therapeutic Area Coverage
Deep domain expertise across 27+ therapeutic areas, essential for CI that goes beyond surface, level signal aggregation.
Who We Serve
Intelligence for Every Stakeholder
Our deliverables are structured to meet the specific intelligence needs of each function within your organization.
Business Development
Asset & Partnership Intelligence
Licensing candidate identification
Asset scouting across indications
Partner network mapping
Deal landscape benchmarking
M&A target screening
Commercial Teams
Launch & Market Intelligence
Launch readiness assessments
Market access intelligence
Payer landscape analysis
Competitor positioning maps
MSL deployment signals
R&D Teams
Pipeline & Trial Intelligence
Competitor trial monitoring
MoA landscape tracking
Endpoint benchmarking
Protocol design intelligence
Biomarker strategy signals
Executive Leadership
Portfolio & Risk Intelligence
Portfolio risk assessment
Strategic scenario planning
Early warning system
Board-ready CI summaries
Investment decision support
Primary Research
KOL Insights, Not Just KOL Mentions
Public filings tell you what a competitor announced. Our KOL network of 1,000+ physicians, payers, and industry experts tells you what's actually happening across the healthcare ecosystem before it becomes a headline.
Case Studies
Measured Impact, Not Just Deliverables
Enterprise buyers need to see outcomes. Here's what we've achieved for clients like you.
Business Development • Neonatal MSC Technology
Out-Licensing Candidate Identification
Identified 25 qualified licensing candidates across US, EU, and Japan - resulting in 3 active partnership discussions within 90 days.
A rare disease biotech engaged DelveInsight to identify licensing partners for their proprietary neonatal MSC platform. Our BD intelligence team combined secondary landscape analysis with primary KOL outreach to surface credible, commercially aligned candidates that purely database-driven approaches missed.
Commercial Intelligence • CDMO Sector
CDMO Competitive Assessment: US & Europe
Supported market expansion strategy through benchmarking of 40+ CDMOs, reducing time-to-decision by 6 weeks versus internal research.
A European CDMO client needed to understand competitive dynamics before entering new geographies. DelveInsight delivered a structured assessment covering technical capabilities, customer mix, pricing posture, and strategic direction across North American and European competitors.
Executive Intelligence • Top 10 Pharma
CI Dashboard for Executive Leadership
Delivered a real-time web-based CI dashboard tracking 12 competitor assets across 4 therapeutic areas, adopted by C-suite within 30 days.
A global pharmaceutical company needed a single pane of glass for their leadership team to track a rapidly evolving competitive landscape. DelveInsight built a bespoke interactive dashboard integrating signal feeds, trend analysis, and competitor alerts into an executive-ready interface.
R&D Intelligence • Diagnostics
In-Vitro Diagnostics Competitor Due Diligence
Delivered structured R&D and regulatory intelligence on 2 key competitors that directly informed a new product development roadmap.
A mid-sized EU diagnostics firm required a detailed understanding of competitor R&D structures, regulatory strategies, and product development efficiency. Our team synthesized public filings, primary interviews, and patent intelligence into an actionable due diligence report.
Client Voices
What CI & Strategy Leaders Say
"The battlecards alone paid for the engagement. Our field team finally has one source of truth instead of five conflicting internal trackers, and it updates itself every time something material happens."
Commercial Director
Mid-Cap Biotech
Immunology"We no longer spend days piecing together competitive updates from multiple sources. DelveInsight delivers a single, reliable view of the market that our commercial and strategy teams trust."
Vice President
Commercial Strategy
Global Specialty Pharma"As a BD lead, I needed licensing candidates that databases alone couldn't surface. DelveInsight's primary research found credible partners that our internal screening had completely missed."
Head of Business Development
Rare Disease Biotech
Rare Diseases"Our team needed competitor trial design intelligence fast, ahead of a protocol decision. DelveInsight's analysts turned around a sourced comparison in days, not the weeks our prior vendor needed."
Director, Clinical Development
CDMO & Specialty Pharma Group
Clinical DevelopmentFAQ
Frequently Asked Questions
How is competitive intelligence different from market research?
Market research focuses on understanding market size, patient populations, and buyer behavior - typically a point-in-time study. CI is continuous, competitor-centric, and action-oriented: it tracks what specific rivals are doing, when, and what it means for your strategy.
What intelligence sources do you monitor?
We monitor 150+ sources including ClinicalTrials.gov, FDA/EMA regulatory databases, PubMed, patent databases, corporate earnings calls, conference abstract portals, hiring signals, and our proprietary KOL network. Primary research is conducted as needed.
How frequently are reports and signals updated?
Signal feeds update continuously. Executive newsletters are weekly. Strategic reports are monthly. Event-driven alerts (FDA decisions, M&A, trial failures) are delivered within hours of the triggering event.
Can intelligence be delivered via custom dashboards?
Yes. We build bespoke interactive CI dashboards for executive teams, commercial functions, and CI analysts. Dashboards can be integrated into your existing tools or delivered as standalone web-based platforms.
Do you provide pre- and post-conference intelligence?
Yes. For major congresses (ASCO, ESMO, AACR, ADA, ASH, and 50+ others), we deliver pre-event program analysis, live abstract monitoring, and post-event competitor positioning summaries within 48 hours of the congress closing.
How do you support launch readiness?
We provide integrated launch intelligence covering competitive positioning, payer access landscape, KOL sentiment, and competitor MSL deployment signals - typically delivered 12–18 months before anticipated launch to support preparation.
Do you provide pre- and post-conference intelligence?
Yes. For major congresses (ASCO, ESMO, ATS, ERS, EULAR, SIRS, and 50+ others), we deliver pre-event program analysis, live abstract monitoring, and post-event competitor positioning summaries within 48 hours of the congress closing.
How do you conduct primary research?
Our extensive KOL network comprises more than 1,000 physicians, payers, and industry experts across key global markets. As part of our CI engagements, we conduct both structured and unstructured interviews, facilitate advisory boards, and organize expert panel discussions to generate actionable insights.
Ready to Elevate Your CI Program?
Let's Build Your Intelligence Advantage
From a single competitive landscape assessment to a fully embedded pharma market intelligence function, explore our competitive intelligence solutions, and we'll scope a plan around your exact needs.
AI-Powered Tools
Explore our intelligence suite
Two purpose-built platforms bringing AI to markets and public health data.
Market Dashboard
DelveInsight's revolutionary AI-powered platform transforms how you access pharmaceutical market insights, instantly, intuitively, and intelligently.
7000+
Reports
Live
Updates
AI
Forecasts
- Real-time query responses
- Centralized market intelligence
- Seamless report integration
Epidemiology Dashboard
DelveInsight's advanced epidemiology database transforms how you access patient population data, making insights faster, smarter, and easier to explore.
500+
Reports
7MM
Coverage
Weekly
REFRESH
- Multi-indication, multi-geography coverage
- AI-powered synthesis across epidemiology models and reports
- Transparent, analyst-grade intelligence you can trust